ML 145
Product Specifications
UNSPSC Description
ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM)[1]. ML 145 has no significant activity for GPR35 at either rodent ortholog[2].
Target Antigen
CXCR; GPR35
Type
Reference compound
Related Pathways
GPCR/G Protein;Immunology/Inflammation
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Inflammation/Immunology; Endocrinology
Assay Protocol
https://www.medchemexpress.com/ml-145.html
Purity
97.04
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(/C=C(S1)/C(N(CCCC(NC2=CC(O)=C(C(O)=O)C=C2)=O)C1=S)=O)=C\C3=CC=CC=C3
Molecular Weight
482.57
References & Citations
[1]Heynen-Genel S, et al. Selective GPR35 Antagonists - Probes 1 & 2. National Center for Biotechnology Information (US); 2010-2010 Feb 28.|[2]Laura Jenkins, et al. Antagonists of GPR35 display high species ortholog selectivity and varying modes of action. J Pharmacol Exp Ther. 2012 Dec;343(3):683-95.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-107536/ML-145-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-107536/ML-145-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1164500-72-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6451970-01 0.1 mL
BACH1 (Breast Cancer 1, Early Onset Breast Cancer, BRCA1-Associated CT Helicase 1, Transcription Regulator Protein BACH1, BTB and CNC Homolog 1m BACH 1, BACH-1) (PE)
Ask
View Details 
MBS6451970-02 5x 0.1 mL
BACH1 (Breast Cancer 1, Early Onset Breast Cancer, BRCA1-Associated CT Helicase 1, Transcription Regulator Protein BACH1, BTB and CNC Homolog 1m BACH 1, BACH-1) (PE)
Ask
View Details 